JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, Y. N.
Right arrow Articles by Johnson, S. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, Y. N.
Right arrow Articles by Johnson, S. W.

Presynaptic inhibition of gamma-aminobutyric acidB-mediated synaptic current by adenosine recorded in vitro in midbrain dopamine neurons

YN Wu, NB Mercuri and SW Johnson

Department of Pharmacology, Oregon Health Sciences University, Portland, USA.

Adenosine receptor antagonists such as caffeine cause dopamine- dependent behavioral arousal and hyperlocomotion in rodents. In the present study, we used the whole-cell recording technique in the rat brain slice to investigate effects of adenosine on dopamine neurons and their synaptic inputs in the substantia nigra zona compacta and ventral tegmental area. Adenosine was most potent for inhibiting the amplitude of the inhibitory postsynaptic current (IPSC) mediated by gamma- aminobutyric acid (GABA)B receptors (EC50 = 47 +/- 3 microM) compared with inhibition of the GABAA-mediated IPSC (117 +/- 51 microM) and the excitatory amino acid-mediated excitatory postsynaptic current (119 +/- 36 microM). Adenosine failed to inhibit current evoked by exogenous GABA or baclofen, suggesting that adenosine acted presynaptically to reduce GABA release from nerve terminals. Adenosine inhibited the GABAB- mediated IPSC by acting at the adenosine A1 receptor, because its effect was blocked by the selective adenosine A1 receptor antagonist 8- cyclopentyl-1,3-dipropylxanthine (100 nM), as well as by the methylxanthines caffeine (1 mM) and theophylline (300 microM). The rank- order of potency of adenosine agonists [N6-cyclohexyladenosine > R-(-)- N6-(2-phenylisopropyl)-adenosine = N6- cyclohexyladenosine > 5'-N- ethylcarboxamidoadenosine > 2-chloroadenosine] also was consistent with activation of the adenosine A1 receptor, whereas the selective adenosine A2A agonist CGS 21680 [2-p-(2-carboxyethyl)phenethylamino-5'- N-ethylcarboxamido adenosine] had no effect on the GABAB IPSC. None of the adenosine agonists or antagonists affected holding current or membrane conductance.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 273, Issue 2, pp. 576-581, 05/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Physiol.Home page
C. Xiao, C. Zhou, K. Li, and J.-H. Ye
Presynaptic GABAA receptors facilitate GABAergic transmission to dopaminergic neurons in the ventral tegmental area of young rats
J. Physiol., May 1, 2007; 580(3): 731 - 743.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
D. Centonze, E. Saulle, A. Pisani, G. Bernardi, and P. Calabresi
Adenosine-mediated inhibition of striatal GABAergic synaptic transmission during in vitro ischaemia
Brain, September 1, 2001; 124(9): 1855 - 1865.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. T. Williams, M. J. Christie, and O. Manzoni
Cellular and Synaptic Adaptations Mediating Opioid Dependence
Physiol Rev, January 1, 2001; 81(1): 299 - 343.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
C. D. Fiorillo and J. T. Williams
Selective Inhibition by Adenosine of mGluR IPSPs in Dopamine Neurons After Cocaine Treatment
J Neurophysiol, March 1, 2000; 83(3): 1307 - 1314.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
B. K. Tolliver, L. B. Ho, L. M. Fox, and S. P. Berger
Necessary Role for Ventral Tegmental Area Adenylate Cyclase and Protein Kinase A in Induction of Behavioral Sensitization to Intraventral Tegmental Area Amphetamine
J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 38 - 47.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
A. Bonci, P. Grillner, N. B. Mercuri, and G. Bernardi
L-Type Calcium Channels Mediate a Slow Excitatory Synaptic Transmission in Rat Midbrain Dopaminergic Neurons
J. Neurosci., September 1, 1998; 18(17): 6693 - 6703.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Bonci and J. T. Williams
Increased Probability of GABA Release during Withdrawal from Morphine
J. Neurosci., January 15, 1997; 17(2): 796 - 803.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. Federici, S. Natoli, G. Bernardi, and N. B. Mercuri
Dopamine selectively reduces GABAB transmission onto dopaminergic neurones by an unconventional presynaptic action
J. Physiol., April 1, 2002; 540(1): 119 - 128.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1995 by the American Society for Pharmacology and Experimental Therapeutics.